Contrasting Verano (OTCMKTS:VRNOF) and Heart Tronics (OTCMKTS:HRTT)

Heart Tronics (OTCMKTS:HRTT) and Verano (OTCMKTS:VRNOF) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

Profitability

This table compares Heart Tronics and Verano’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Heart Tronics	N/A	N/A	N/A
Verano	-41.68%	-9.54%	-4.51%

Valuation and Earnings

This table compares Heart Tronics and Verano”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heart Tronics	N/A	N/A	N/A	N/A	N/A
Verano	$878.59 million	0.52	-$341.86 million	($0.98)	-1.29

Heart Tronics has higher earnings, but lower revenue than Verano.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Heart Tronics and Verano, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heart Tronics	0	0	0	0	0.00
Verano	1	0	0	1	2.50

Given Heart Tronics’ higher possible upside, analysts plainly believe Heart Tronics is more favorable than Verano.

Insider and Institutional Ownership

9.0% of Verano shares are held by institutional investors. 9.1% of Verano shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Verano beats Heart Tronics on 5 of the 9 factors compared between the two stocks.

About Heart Tronics

Heart Tronics, Inc., a medical device company, engages in the research, development, and marketing of medical devices in the United States. Its medical devices are used to monitor and measure physiological signals in order to detect diseases that impact an individual's health. The company offers Fidelity 100 Monitor System, an integrated system in which its component Model 100 Patient Module collects, processes, and amplifies electrocardiogram (ECG) signals from that patient through a set of 10 electrodes that are wirelessly transmitted to the laptop computer. Its products in the development stage include Fidelity 350 Holter Monitor, an ambulatory Holter monitor that collects ECG data of arrhythmia and transient heart disease, while the patient carries out daily activities away from the physician's office or hospital. The company's products in the development stage also consist of Fidelity 200 Event Recording System/Heart Tempo Card, a non-prescription heart monitoring device, which is used as an early-detection device by patients who desire to monitor their condition. Its products also include Cardiac Vest, a lightweight, close-fitting vest or undergarment made of stretchable material in which the electrodes are stitched into the fabric; and Fidelity 400 Intracardiac Monitor that applies its proprietary physiological signal acquisition and amplification technology to read intracardiac signals procured from intracardiac catheter. The company was formerly known as Signalife, Inc. and changed its name to Heart Tronics, Inc. in November 2008. Heart Tronics, Inc. was incorporated in 1987 is headquartered in Studio City, California.

About Verano

Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States. The company engages in the cultivation, processing, wholesale, and retail distribution of cannabis in Arizona, Arkansas, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Nevada, New Jersey, Ohio, Pennsylvania, and West Virginia. It offers cannabis products under the Encore, Avexia, MUV, Savvy, BITS, and Verano brands for medical and adult-use markets. The company is headquartered in Chicago, Illinois.